RedHill Biopharma Provides Update on Ongoing Phase III and Phase II studies with BEKINDAÂ and Expected Timing of TopLine Results

Topline results from both the ongoing Phase III clinical study for acute gastroenteritis and gastritis and the ongoing Phase II clinical study for diarrheapredominant irritable bowel syndrome IBSD are expected in mid2017ÂÂ Over twothirds of the planned ...